Overview
For use in calves 1-5 days of age, as a one-time immunotherapeutic treatment for reduction of mortality and clinical signs associated with calf scours caused by E. coli K99 diarrhea in neonatal calves.
Dosage: Aseptically administer 1 ml intravenously. 21 day slaughter withdrawal.
Early administration in the disease process stimulates non-antigen related defense mechanisms and enhances calf's innate immune defense system to minimize and control damage caused by pathogenic E. coli.
Anaphylactoid reactions may occur. Antidote: Epinephrine.
U.S. Lic. No. 289.
Manufacturer Label
Safety Data Sheet (SDS)
Amplimune Immunostimulant
18228
USDA-approved immunotherapeutic agent for bovine infectious disease
For use in calves 1-5 days of age, as a one-time immunotherapeutic treatment for reduction of mortality and clinical signs associated with calf scour… Read More Read More
Features & Benefits
- An antibiotic alternative for calf scours
- Low volume, single-dose therapy
Overview
For use in calves 1-5 days of age, as a one-time immunotherapeutic treatment for reduction of mortality and clinical signs associated with calf scours caused by E. coli K99 diarrhea in neonatal calves.
Dosage: Aseptically administer 1 ml intravenously. 21 day slaughter withdrawal.
Early administration in the disease process stimulates non-antigen related defense mechanisms and enhances calf's innate immune defense system to minimize and control damage caused by pathogenic E. coli.
Anaphylactoid reactions may occur. Antidote: Epinephrine.
U.S. Lic. No. 289.
Manufacturer Label
Safety Data Sheet (SDS)
PBS Animal Health 5-Point Promise – Vaccines Done RIGHT!

Shipping Information for Temperature Sensitive Items
(Vaccines and Other Refrigerated Items)
Product Reviews